DA Davidson keeps a Buy rating and $150 price target on Amazon.com while discussing some of the recent management changes announced by the company. According to CNBC, Trent Green is succeeding Amir Dan Rubin as the CEO of One Medical, and the firm believes that Amazon’s healthcare-related efforts could serve as an important future sales catalyst, estimating a “greater than 10% chance” that the company can generate an incremental 100 basis points of revenue growth in 2026 by exploiting healthcare, where a total addressable market is $19T. DA Davidson further notes that in a blog post on September 1, CEO Andy Jassy has announced that the company added three new executives to its senior leadership group called the S-Team: Dave Brown (VP, AWS), Aicha Evans (CEO, Zoox), Swami Sivasubramanian (VP, AWS). AI can be a future catalyst for sales, and the firm contends that there is almost a 100% chance Amazon can generate an incremental 100 basis points of revenue growth in 2026 by exploiting AI, between its AWS-related and e-commerce efforts, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AMZN:
- 3 Best Stocks to Buy Now, 9/7/2023, According to Top Analysts
- Big Tech Giants Apple (NASDAQ: AAPL), Amazon, and Google Face Tough New Rules in the EU
- FTC lawsuit against Amazon ‘unlikely to be a surprise,’ says BofA
- Amazon (NASDAQ:AMZN) Inches Closer to Potential FTC Lawsuit
- FTC Amazon.com antitrust lawsuit set for later this month, WSJ says